ADC Therapeutics to Present at November Investor Conferences
PR Newswire•03/11/2026•07:15 ET
0
Key Highlights
- ➤ADCT to present at Guggenheim Healthcare Innovation Conference November 10
- ➤ADCT to present at Jefferies Global Healthcare Conference November 19
- ➤CEO Ameet Mallik will participate in both investor conference fireside chats
- ➤ZYNLONTA holds accelerated FDA and conditional European Commission approvals for relapsed/refractory DLBCL
ADC Therapeutics to Present at November Investor Conferences PR Newswire
LAUSANNE, Switzerland, Nov. 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two upcoming investor conferences in November:
Get started
Create a free account to read the full story.